Invention Grant
- Patent Title: Heterocyclic kinase inhibitors
-
Application No.: US15304131Application Date: 2015-04-16
-
Publication No.: US10280184B2Publication Date: 2019-05-07
- Inventor: Michael M. Friedman , Philip Cox , Kristine E. Frank , Michael Z. Hoemann , Augustine Osuma , Noel S. Wilson , Xiangdong Xu , Kevin Cusack , Raymond Huntley , J. Martin Herold
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Foley Hoag LLP
- Priority: WOPCT/CN2014/075560 20140417
- International Application: PCT/CN2015/076766 WO 20150416
- International Announcement: WO2015/158283 WO 20151022
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00 ; A61K31/437 ; C07D487/04 ; C07D498/04

Abstract:
The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Public/Granted literature
- US20170114077A1 HETEROCYCLIC KINASE INHIBITORS Public/Granted day:2017-04-27
Information query